BANK OF AMERICA CORP /DE/
BankPosition in GLUE — Monte Rosa Therapeutics, Inc.
CIK 70858
CHARLOTTE, NC
Position in GLUE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,160,375
-$214,690 QoQ
Shares Held
254,561
-34.3% QoQ
Ownership
0.298%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 193 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. GLUE ranks #130 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in GLUE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,160,375 | 254,561 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,375,065 | 387,542 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $3,505,592 | 223,571 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,998,053 | 269,643 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $1,222,948 | 271,164 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $120,848 | 26,045 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $439,183 | 63,283 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $389,120 | 73,419 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $256,200 | 68,503 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $437,867 | 62,109 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $455,993 | 80,707 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $390,863 | 81,600 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $575,824 | 84,062 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $388,891 | 49,922 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $602,323 | 79,149 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $868,691 | 106,327 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,220,740 | 126,240 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,070,388 | 147,674 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,340,695 | 65,656 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,771,282 | 79,501 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||